President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

Work has begun in the UK on developing new tests that will spot if someone has “fat genes”. The project, which seeks to ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug with fewer ...

If you value the S&P 500 on earnings, its price-to-earnings ratio of 28 is also significantly above its historical norms. The Vanguard FTSE Developed Markets ETF trades at 15.5 times earnings today, a ...

Factories in China Factories in China are posting content on social platforms about the true cost to produce a luxury He ...

Novo Nordisk has doubled down on position in the sickle cell disease (SCD) category with a $1.1 billion agreement to acquire Forma Therapeutics, and its therapeutic candidate etavopivat ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...